First treatment trial for West Nile infection begins.
Quirk
Mary
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011994:Recombinant Proteins; D014901:West Nile Fever / Q000188:drug therapy*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins